Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Drug firm

Cadila Healthcare Gets DCGI Nod To Conduct Phase III Trials For Two-Dose COVID Vaccine

Shares of Cadila Healthcare Ltd were trading at Rs 563.95 per scrip on BSE, up 0.29 percent from their previous close

Read More

Eli Lilly To Transfer Rights Of Two Diabetes Products To Cipla

The Gurgaon-based firm, which is a wholly-owned subsidiary of US-based Eli Lilly and Company, has inked a pact with Cipla in this regard.

Read More

Zydus Cadila Gets USFDA Nod To Market Depression Treatment Drug In US Market

The drug will be manufactured at the group''s formulation manufacturing facility at the SEZ, Ahmedabad, Zydus Cadila noted.

Read More

Dr Reddy''s Launches Minoxidil For Treatment Of Female Pattern Hair Loss In India

The launch follows the first-ever approval of the additional indication by the Central Drugs Standard Control Organisation (COSCO) in India for the use of the product for the treatment of female pattern hair loss (FPHL)

Read More

Panacea Biotec Supplies Second Component Of Sputnik V Vaccine In India

Sputnik V has pioneered the use of heterogeneous boosting (two different vectors for the two shots in a course of vaccination among COVID vaccines).

Read More

Lupin Launches Pressurised Metered Dose Inhaler In UK

Shares of Lupin Ltd on Tuesday closed at Rs 940.90 per scrip on the BSE, up 1.75 per cent from its previous close.

Read More

Astrazeneca Pharma India Q1 Net Profit Declines 45 % To Rs 10.24 Cr

Revenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago

Read More

Abbott India Q1 Net Profit Up 8.5 % To Rs 195.76 Cr

Shares of Abbott India were trading at Rs 17,666.10 per scrip on BSE, down 1.51 per cent from its previous close.

Read More

Glenmark Inks Deal With Sanotize For COVID Treatment Spray In India, Other Asian Mkts

SaNOtize developed and patented a Nitric Oxide Releasing Solution platform technology (NORSTM) to treat and prevent microbial infections in 2017.

Read More

Lupin To Acquire Australia-Based Southern Cross Pharma

This will significantly increase Lupin's value proposition and market share in the Australian market

Read More

Alkem Laboratories Says USFDA Inspection At Taloja Facility Ends With 'Zero' Observations

Shares of Alkem Laboratories were trading 0.30 per cent lower at Rs 3,362.05 apiece on BSE.

Read More

Torrent Pharma Q1 Net Profit Up 2.8 % To Rs 330 Cr

Consolidated revenue from operations of the company stood at Rs 2,134 crore for the quarter under consideration. It was Rs 2,056 crore for the same period a year ago

Read More

Sanofi India Reports Q2 Net Profit At Rs 178.3 Cr

Revenue from operations of the company stood at Rs 789.1 crore for the quarter under consideration. It was Rs 710.5 crore for the same period a year ago

Read More

GlaxoSmithKline Pharma Q1 Net Profit Up 9 % At Rs 121 Cr

Shares of GlaxoSmithKline Pharmaceuticals Ltd closed at Rs 1,726.20 per scrip on BSE, up 2.65 per cent from the previous close.

Read More

Alembic Pharmaceuticals Shares Tumble Nearly 4 % After Q1 Earnings

The total expenses incurred by the company for the quarter ended June 30, 2021, stood at Rs 1,145.37 crore. It was Rs 982.13 crore for the year-ago period

Read More